SEPN
SEPN
NASDAQ · Pharmaceuticals

Septerna Inc

$47.35
-0.53 (-1.11%)
As of Nov 7, 1:53 AM ET ·
Financial Highlights (FY 2026)
Revenue
48.46M
Net Income
-51,550,016
Gross Margin
—
Profit Margin
-106.4%
Rev Growth
—
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — 51.4% 51.4% 51.4%
Operating Margin -148.6% 37.7% 41.6% 40.2%
Profit Margin -106.4% 30.9% 31.1% 30.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 48.46M 203.59M 209.55M 172.61M
Gross Profit — 104.74M 107.80M 88.80M
Operating Income -72,026,102 76.67M 87.11M 69.31M
Net Income -51,550,016 62.98M 65.23M 53.09M
Gross Margin — 51.4% 51.4% 51.4%
Operating Margin -148.6% 37.7% 41.6% 40.2%
Profit Margin -106.4% 30.9% 31.1% 30.8%
Rev Growth — +1.5% +13.6% +0.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 152.75M 171.86M 171.94M
Total Equity — 626.19M 687.13M 754.44M
D/E Ratio — 0.24 0.25 0.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -70,337,486 113.38M 119.42M 97.18M
Free Cash Flow — 53.53M 45.52M 42.56M